NCT05525637: Safety and Efficacy Study of YZJ-1139 in Insomnia Disorder |
|
|
| Recruiting | 3 | 1041 | RoW | YZJ-1139 20mg, YZJ-1139 40mg, Placebo | Shanghai Haiyan Pharmaceutical Technology Co., Ltd. | Insomnia Disorder | 12/24 | 12/24 | | |
NCT05191368: Safety and Immunogenicity of Sars-cov-2 Vaccine in Patients With Rheumatic Diseases |
|
|
| Recruiting | N/A | 200 | RoW | No intervention | Yunnan University of Chinese Medicine | To Collect Clinical Information and Test Blood Samples of Healthy People and Patients With Rheumatic Diseases | 06/22 | 06/22 | | |